Important announcement concerning Temple Health and Keystone First. Our provider agreement with Keystone First, is scheduled to end on July 31st. Learn about your options to continue receiving care at Temple Health.
Accutest Research Laboratory (ARL) and Fox Chase Cancer Center formed a partnership under which Accutest will assist with expanding the Fox Chase clinical research footprint abroad. ARL is a leading global independent and internationally accredited CRO, offering the highest quality standards and has a strong regulatory track record. ARL has capabilities to execute Phase II to IV clinical trials in Asia and Latin America.
About Our Partnership
Memorandum of Understanding.
Potential clinical trial collaborations in Asia and Latin America.